Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      As GLP-1 Spending Climbs, Employers Need to Look Beyond Price


      News provided by

      US-Rx

      Nov 17, 2026, 08:04 ET

      Share this article

      Share this article


      As utilization grows and new purchasing channels emerge, US-Rx Care CEO Renzo Luzzati says employers need to assess clinical eligibility, sourcing, and total net cost alongside negotiated discounts.

      TAMARAC, Fla., Nov. 17, 2026 /PRNewswire/ -- GLP-1 medications are taking a growing share of employer pharmacy budgets, pushing self-funded plans to look beyond negotiated discounts and examine who qualifies for treatment, where medications are sourced and what the plan ultimately pays. Nearly eight in 10 employers surveyed by Business Group on Health said these medications are increasing their healthcare costs. "GLP-1s have made a huge difference in care for people with diabetes and weight loss. We haven't seen medications this effective in a long time," said Renzo Luzzatti, CEO of US-Rx Care. "The challenge is affordability."

      Continue Reading
      “GLP-1s have made a huge difference in care for people with diabetes and weight loss. We haven’t seen medications this effective in a long time. The challenge is affordability.” - Renzo Luzzatti, CEO of US-Rx Care
      “GLP-1s have made a huge difference in care for people with diabetes and weight loss. We haven’t seen medications this effective in a long time. The challenge is affordability.” - Renzo Luzzatti, CEO of US-Rx Care

      Coverage decisions are already diverging. Business Group on Health found that 67% of surveyed employers cover GLP-1 medications for weight management. Among those employers, 72% said they were likely to continue that coverage in 2027. The International Foundation of Employee Benefit Plans (IFEBP) found that 60% of surveyed employers cover GLP-1s for diabetes only, while 36% cover them for both diabetes and weight loss.

      Appropriate Use Changes the Cost Equation

      Eligibility criteria and prior-authorization review can affect utilization. Across US-Rx Care's book of business, GLP-1 spending for diabetes averages below industry benchmarks. Its utilization-management process includes reviewing medical records to validate a type 2 diabetes diagnosis, assess hemoglobin A1C levels, and evaluate the patient's current medication regimen against the plan's coverage criteria.

      That review can identify prescriptions that do not match a plan's coverage rules. "We find individuals that have been approved for GLP-1 therapy by their prior PBM that are not diabetic," Luzzatti said. "The plan doesn't cover weight loss, which means that they're going on the product for weight loss, even though the plan doesn't cover it."

      The financial impact grows when weight-loss treatment is covered. Luzzatti has seen GLP-1s account for 20% to 25% of total pharmacy spending in some employer plans covering obesity treatment. At that level, utilization becomes a material cost factor alongside the price paid for each prescription. "It's just that not everybody needs to be on a GLP-1," Luzzatti said. "That's where clinical oversight and management come in."

      New Channels Expand the Price Comparison

      Employers and members also have more ways to obtain GLP-1 medications than they did when the drugs first entered the market. Manufacturer programs, direct-to-consumer (DTC) platforms, cash-pay options, and direct-to-employer arrangements are creating alternatives to the traditional contracted pharmacy channel. IFEBP found that 27% of surveyed employers encourage employees to use DTC platforms for these medications.

      The savings opportunity can differ by indication. Luzzatti said direct purchasing offers less room for savings on diabetes treatment than on weight-loss medications. "Unfortunately, there's not a lot of savings when you look at diabetes, but if you look at weight loss, there is more opportunity for savings," he said.

      The comparison depends on how the employer has designed the benefit. When the employer covers the medication, the plan can compare its contracted pharmacy cost with available direct-to-employer purchasing options. If the medication is not covered, the member may instead purchase it through a lower-cost cash-pay channel. "Cash-pay can still give the member a lower-cost option," Luzzatti said.

      Total Plan Cost Extends Beyond Rebates

      Rebate guarantees capture only one part of GLP-1 spending. Total pharmacy cost is also shaped by which prescriptions are approved, how frequently the drugs are used, the price available through different purchasing channels, and the amount members are expected to contribute.

      Those decisions may become more frequent as GLP-1 indications expand and additional oral options become available for more patients. Luzzatti said patients who previously avoided GLP-1s because they did not want an injection may be more willing to use an oral version, creating the potential for additional demand.

      In addition, as manufacturers reduce prices, rebates can become less significant. The plan's net cost after member cost sharing then becomes a more important measure of overall spending. If prices fall enough, employer cost concerns may decline, making broader access for plan enrollees possible.

      About US-Rx Care
      US-Rx Care is revolutionizing America's pharmacy benefits system by replacing opaque, profit-driven PBMs with a transparent, fiduciary model that puts employers and members first. Founded in 2007, the company combines clinical rigor, ethical contracting, and data-driven oversight to cut drug costs by up to 50% or more while also improving health outcomes. Operating under a legally binding ERISA fiduciary standard, US-Rx Care eliminates conflicts of interest, passes through 100% of manufacturer rebates and pharmacy discounts, and delivers measurable savings without compromising care. Privately owned and free from outside financial influence, US-Rx Care is setting the new standard for pharmacy benefit management—restoring trust, accountability, and real control for employers, benefits consultants, and health plans nationwide.  Website: www.us-rxcare.com

      References:

      • Business Group on Health. (2026, May 5). GLP-1 costs loom large for employers, forcing challenging coverage decisions, Business Group on Health survey finds. businessgrouphealth.org/newsroom/news-and-press-releases/press-releases/2026-glp-1-survey
      • Plier, R. (2026, July 7). GLP-1 drugs survey report: What employers are—and aren't—covering in 2026. International Foundation of Employee Benefit Plans. ifebp.org/resources---news/news-and-regulatory-updates/press-room/press-releases/2026/07/07/glp-1-drugs-survey-report--what-employers-are-and-aren't-covering-in-2026
      • Pharmacy Technology & Management Review. (n.d.). The GLP-1 revenue trap: How fiduciary benefit management exposes the PBM profit playbook. ptmreview.com/glp-1-pricing-pbm-reform-pharmacy-margins/

      Media Inquiries:
      Karla Jo Helms
      JOTO PR™
      727-777-4629
      Jotopr.com

      SOURCE US-Rx

      Modal title

      Also from this source

      Before Choosing a Transparent PBM, Employers Should Ask These 10 Questions

      Before Choosing a Transparent PBM, Employers Should Ask These 10 Questions

      Employer pharmacy costs are rising faster than healthcare costs overall. Business Group on Health estimates drug costs will increase 12% in 2026,...

      Good Employers Keep Choosing the Wrong PBM Because They Start With the Wrong Metrics

      Good Employers Keep Choosing the Wrong PBM Because They Start With the Wrong Metrics

      Employers have spent decades chasing bigger discounts and richer rebates in PBM bids. Yet pharmacy costs keep rising. According to US-Rx Care, many...

      More Releases From This Source

      Explore

      Pharmaceuticals

      Pharmaceuticals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Health Care & Hospitals

      Health Care & Hospitals

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.